System C buys the drug management specialist Wellsky


System C has acquired drug management specialist Wellsky to try to bolster its electronic patient record (EPR) offering and compete with U.S. rivals.

WellSky International, formerly known as JAC, is best known for its electronic prescription and drug delivery (EPMA) solutions. These solutions are used by some 200 NHS trusts and health councils in England, Scotland, Wales and Northern Ireland, as well as various international clients.

The company, which employs 70 people in the UK, has the widest range of pharmacy and EPMA products on the UK NHS market, including prescription areas such as chemotherapy and paediatrics.

System C described the acquisition as highly strategic and said it would integrate Wellsky into its EPR suite in the Careflow cloud, including clinical collaboration, care planning, electronic observations, and patient flow.

“System C will invest significantly in product innovation, maintain interoperability with all in-hospital software systems and external vendors,” the company said in a statement.

Dr Ian Denley, Joint CEO of System C, added: “WellSky International leads the market in drug management solutions and has a long history of collaborating with clinicians across the NHS. Its highly evolved clinical products are considered by users with the utmost consideration and we are delighted to have joined the System C group ”.

Markus Baw, joint CEO of System C, told Digital Health News that while the company “has a good prescription module,” they don’t have “the breadth that Wellsky covers,” as EPMA is very complex. “.

He also confirmed that work had already begun to integrate Wellsky into the System C EPR.

“It’s really good to have a recipe fully integrated into an EPR, as you can get a lot of benefits,” he explained.

Cerner and Epic have integrated EPMA capabilities and System C expects the acquisition to help them compete with their NHS competitors.

WellSky’s extensive EPMA product portfolio includes critical care, emergency care, theaters, controlled medications and mobile solutions to provide in-bed closed loop solutions.

Bolton said the addition of a closed-loop EPMA solution will allow System C to help its customers obtain HIMSS 6 and 7 accreditation, a benchmark promoted through the Global Digital Exemplary program.

Robert Tysall-Blay, CEO of WellSky International, added: “System C is a good cultural fit for us and has the ambition, scale and range of products we need to deliver a drug management platform. world-class as part of an integrated EPR “.

The terms of the agreement were not disclosed

Source link